News & Events

The clinical trial was random, regulated, double-blinded and broad-based. The drug was tested on 457 patients, aged 16-45, who had been diagnosed with Type 1 diabetes a short time before joining the trial. The trial took place in around 40 medical centers in Europe, Israel and South Africa.

WATEC 2011 Conference - Where Innovation meets Implementation and creates partnership

One of the most significant challenges in the global environment arena today is Innovation to Implementation - "i2i". In order to overcome the "i2i" challenges we assume that we should initiate partnership that can provide: Know How in the local markets, credibility, local experience and financial leverage, and has the power to improve the situation of billions of people.

At WATEC 2011 Conference, the world key decision-makers will contribute to the debates on "i2i" challenges - and will craft the solution toward partnership between all involved.

TEL AVIV, Israel, June XX, 2011 – Abbott and Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science (WIS), have signed a three-year agreement in which Abbott will fund research programs at the Weizmann Institute of Science in selected health care fields.

Celebrate With Us The 10th Anniversary of The ILSI-BioMed Conference.
It is our honor and pleasure to invite you to participate in ILSI-Biomed 2011 Conference to be held May 23-25, 2010 in Tel-Aviv.

Ben-Gurion University of the Negev (BGU) and France Telecom (Orange Labs R&D) have agreed to collaborate on research applying "location theory" to determine the optimal placement of their Internet routers, which will enhance services like video streaming.

The Eilat-Eilot Renewable Energy International Conference and Exhibition is among the world’s leading platforms for presenting technological innovation, business opportunities, policies and implementation in the renewable energy field. The conference brings together thousands of participants from all over Israel and abroad. February 22-24, 2011 • Save the date!

Israel is recognized over the world as a leading source of knowledge and innovation in advanced research and technology. Israel's technological achievements are at the forefront of communications, electronics, computer software, networking, defense, security and life sciences industries.
More than 100 major International technology firms maintain active R&D centers in Israel.
The event will take place at the Dan Panorama hotel in Tel Aviv during 8-9 of November.

BEER-SHEVA, Israel; October 7, 2010 — The Arava group, initiated by the Eilat-Elot municipality and Ben-Gurion University of the Negev (BGU), recently won a tender from the Israeli Ministry of Industry, Trade and Labor to establish and operate a technology center for renewable energy in the south of the country. The government of Israel and the group will each invest half of $30 million (114 million Shekels) over a five-year period. BGU, represented by BGN Technologies, the University's technology transfer company, has joined the group commitment to invest in the long-term development of industry in the region.

Hadasit offers comprehensive customized preclinical professional services to the domestic and international biotechnology,
pharmaceutical and medical device industries at Hadassah.

A place for all things bio and med, where Israel’s vibrant life science community comes together.